SAK CORP
CIK 1061088 · last filed 2014-08-12
SAK CORP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2010. Across all open-market trades the lifetime net is +$157.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $15.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.95M
2
4
$157.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | 10%+ Owner | 53,331,109 | — | — | $320.19M | 1 | 2014-02-04 |
| FACT | 10%+ Owner | 1,500,000 | $10.63 | $15.95M | -$162.50M | 2 | 2010-04-12 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-08-12 | — | Other (J) | −159,993,327 | -$3.92B | |
| 2014-02-04 | IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Buy (P) | +49,260,723 | $320.19M | EDGAR |
| 2010-04-12 | FACT | Sell (S) | −1,500,000 | -$40.44M | EDGAR |
| 2010-03-17 | FACT | Sell (S) | −4,520,625 | -$122.06M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.